Evidence map›Paper›PMID 33997055›Full record

ArticleJournal of immunology research2021

Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates.

Amin Hadi, Abbas Rastgoo, Maryam Eskandarian, Nooshin Haghighipour, Azam Bolhassani

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Amin HadiCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0003-0668-8398
Abbas RastgooSchool of Mechanical Engineering, University of Tehran, Tehran, Iran.ORCID https://orcid.org/0000-0003-0068-6535
Maryam EskandarianDepartment of Immunology, Tarbiat Modares University, Tehran, Iran.ORCID https://orcid.org/0000-0003-1834-3645
Nooshin HaghighipourNational Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0003-3605-6770
Azam BolhassaniDepartment of Hepatitis and AIDs, Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0001-7363-7406
Pasteur Institute of Iran · IRTarbiat Modares University · IRUniversity of Tehran · IRYasuj University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An effective therapeutic vaccine to eradicate HIV-1 infection does not exist yet. Among different vaccination strategies, cell-based vaccines could achieve in clinical trials. Cell viability and low nucleic acid expression are the problems related to dendritic cells (DCs) and mesenchymal stem cells (MSCs), which are transfected with plasmid DNA. Thus, novel

Indexed as

AIDS VaccinesAnimalsBioreactorsDendritic CellsFemaleHIV-1HIV InfectionsHumansImmunogenicity, VaccineMaleMesenchymal Stem CellsMiceModels, Animalnef Gene Products, Human Immunodeficiency VirusPlasmidsPrimary Cell CultureAIDS Vaccinesnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1Recombinant Proteins

Identifiers

PMID33997055
PMCPMC8081596
OpenAlexW3154931452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.